Feb 9th, 2021

Tilray CEO on Grow Deal, Aphria Merger, Pot Legalization

Tilray CEO Brendan Kennedy discusses the pact with Grow Pharma to distribute Tilray's medical cannabis products in the U.K., the agreed merger with Aphria, and the outlook for U.S. legalization of marijuana on "Bloomberg Markets: The Close." (Source: Bloomberg)